Last Price$82.1(0.4%)
Market Cap$37.4B
0.6%
Peers median - 8.0%
7.9%
Peers median - 14.6%
17.4%
Peers median - 4.8%
10.9%
Peers median - 3.7%
Competing with GEHC
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$37.4B | 5.7 | $132.4 61.2% undervalued | (9.2%) | $19.7B | $1,550.0M | 0.6% | 7.9% | 41.7% | 10.9% | 17.4% | |
$38.0B | 7.7 | $144.6 38.8% overvalued | 3.5% | $2,746.6M | $1,078.5M | 16.2% | 39.3% | 74.5% | 38.8% | 1.3% | |
$11.4B | 8.2 | $23.2 62.2% overvalued | 119.9% | $550.2M | $238.8M | 17.5% | 43.4% | 90.2% | 69.3% | 1.3% | |
$8,792.1M | 6.3 | $55.2 45.7% overvalued | 22.6% | $1,150.3M | ($162.0M) | 18.5% | (14.1%) | 58.4% | 4.8% | 5.1% | |
$6,040.3M | 6.0 | $12.5 12.9% overvalued | 33.2% | $2,463.7M | $186.4M | 11.4% | 7.6% | 19.2% | 2.5% | 83.1% | |
$2,832.8M | 5.7 | $2,568.9 10,776.0% undervalued | 17.3% | $1,736.4M | $109.3M | 4.7% | 6.3% | 10.2% | 0.0% | 0.0% | |
$1,778.8M | 6.6 | $29.6 39.7% undervalued | (41.6%) | $1,167.2M | $173.7M | 7.2% | 14.9% | 21.7% | 20.1% | 4.6% | |
$1,747.5M | 5.7 | $53.3 187.5% undervalued | (11.2%) | $1,181.3M | $368.5M | (10.2%) | 31.2% | 66.5% | (2.6%) | 9.4% | |
$1,721.0M | 5.6 | $6.2 42.2% overvalued | (40.9%) | $385.1M | $73.4M | 8.7% | 19.1% | 53.1% | 0.8% | 2.9% | |
$1,694.3M | 6.4 | $7.0 55.6% undervalued | (31.8%) | $792.3M | $113.5M | 5.6% | 14.3% | 89.8% | 10.1% | 7.8% | |
$1,516.9M | 5.6 | $40.7 23.7% undervalued | 19.9% | $1,112.2M | $139.4M | (3.0%) | 12.5% | 42.6% | (0.7%) | 29.9% |
Compare GEHC Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
GE HealthCare Technologies Inc.GEHC
1.8x
0.6%
43.8%
10.1%
Median Peer Set
2.5x
8.0%
0.0%
3.4%
Certara, Inc.CERT
4.1x
8.7%
(78.5%)
(3.1%)
Doximity, Inc.DOCS
19.2x
13.5%
34.5%
31.0%
GoodRx Holdings, Inc.GDRX
1.6x
5.6%
N/A
2.1%
HealthEquity, Inc.HQY
7.5x
16.0%
N/A
5.6%
Omnicell, Inc.OMCL
1.4x
(3.0%)
N/A
1.1%
Progyny, Inc.PGNY
1.3x
7.2%
(9.2%)
4.7%
Premier, Inc.PINC
1.5x
0.8%
(28.6%)
8.9%
Privia Health Group, Inc.PRVA
(281.2x)
4.7%
(40.0%)
0.8%
R1 RCM Inc.RCM
3.3x
24.8%
N/A
0.1%
Veeva Systems Inc.VEEV
12.0x
16.2%
34.9%
26.0%
Compare GEHC Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does GE HealthCare Technologies Inc. (GEHC) revenue growth compare to peers and the industry?
GE HealthCare Technologies Inc. (GEHC) revenue growth is 0.6%, compared to the peers' median of 8.0%.
2. How does GE HealthCare Technologies Inc. (GEHC) Free Cash Flow (FCF) margin compare to peers and the industry?
GE HealthCare Technologies Inc. (GEHC) FCF margin is 7.9%, compared to the peers' median of 14.6%.
3. How does GE HealthCare Technologies Inc. (GEHC) Total Debt to Equity ratio compare to peers and the industry?
GE HealthCare Technologies Inc. (GEHC) Total Debt to Equity ratio is 17.4%, compared to the peers' median of 4.8%.
4. How does GE HealthCare Technologies Inc. (GEHC) ROIC (Return on Invested Capital) compare to peers and the industry?
GE HealthCare Technologies Inc. (GEHC) ROIC is 10.9%, compared to the peers' median of 3.7%.